Baxter

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Baxter 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BAX

Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. It operates through the following segments: Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. 

CEO
Andrew P. Hider
CEOAndrew P. Hider
Employees
37,500
Employees37,500
Headquarters
Deerfield, Illinois
HeadquartersDeerfield, Illinois
Founded
1931
Founded1931
Employees
37,500
Employees37,500

BAX Key Statistics

Market cap
8.87B
Market cap8.87B
Price-Earnings ratio
-10.27
Price-Earnings ratio-10.27
Dividend yield
2.09%
Dividend yield2.09%
Average volume
7.23M
Average volume7.23M
High today
High today
Low today
Low today
Open price
$17.38
Open price$17.38
Volume
0.00
Volume0.00
52 Week high
$32.68
52 Week high$32.68
52 Week low
$15.73
52 Week low$15.73

Stock Snapshot

With a market cap of 8.87B, Baxter(BAX) trades at $17.35. The stock has a price-to-earnings ratio of -10.27 and currently yields dividends of 2.1%.

On 2026-04-09, Baxter(BAX) shares started trading at $17.38, with intraday highs of — and lows of —.

Trading activity shows a volume of 0, compared to an average daily volume of 7.23M.

The stock's 52-week range extends from a low of $15.73 to a high of $32.68.

The stock's 52-week range extends from a low of $15.73 to a high of $32.68.

BAX News

Simply Wall St 3d
Assessing Baxter Valuation After Launch Of IV Verify Line Labeling System

Baxter International (BAX) has launched its IV Verify Line Labeling System at the 2026 American Organization for Nursing Leadership Conference, highlighting a n...

Assessing Baxter Valuation After Launch Of IV Verify Line Labeling System
Simply Wall St 6d
Does Baxter’s New IV Verify Labeling System Redefine Its Automation Edge In Healthcare Workflow Efficiency?

In late March 2026, Baxter International Inc. introduced the IV Verify Line Labeling System in the U.S., an automated bedside labeling solution launched through...

Does Baxter’s New IV Verify Labeling System Redefine Its Automation Edge In Healthcare Workflow Efficiency?

Analyst ratings

78%

of 18 ratings
Buy
16.7%
Hold
77.8%
Sell
5.6%

People also own

Based on the portfolios of people who own BAX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.